Pharmaceutical Benefits Scheme definition

Pharmaceutical Benefits Scheme or “PBS” means the scheme under which the Federal Government heavily subsidises the cost of medicines. We do not pay for medicines on the PBS. It is available to Australian residents and eligible visitors from countries with reciprocal arrangements with Australia. For more information about the PBS visit health.gov.au
View Source
Pharmaceutical Benefits Scheme or “PBS” means the Commonwealth Scheme for the payment of pharmaceutical benefits detailed in Part VII of the National Health Act.
View Source

Examples of Pharmaceutical Benefits Scheme in a sentence

  • The 6CPA includes three key funding elements: • community pharmacy remuneration; • ensuring that all Australians have timely access to the Pharmaceutical Benefits Scheme (PBS) medicines they require regardless of the cost of the medicine or where they live; and • community pharmacy programs directed at improving consumer management of their medications and delivering primary healthcare services through community pharmacy.

  • The Commonwealth also provides some clinical and non-clinical community based mental healthcare and subsidises private specialist mental healthcare via the MBS and the Pharmaceutical Benefits Scheme (PBS).

  • In addition to the base coverage benefits provided under clause 3.2, the Insurer may offer, and make available, a higher level of benefits payable and scope of cover under a base OSHC product, where those benefits are for pharmaceutical items listed under the Pharmaceutical Benefits Scheme or for items listed in the Australian Register of Therapeutic Goods.

  • The Commonwealth will collect and share data on Commonwealth funded mental health and suicide prevention services, including Primary Heath Network (PHN) services and consumer outcome data, Medicare Benefits Scheme (MBS) and Pharmaceutical Benefits Scheme (PBS) data, and continue to develop and refine those collections to improve system coverage and national consistency.

  • The Seventh Community Pharmacy Agreement (7CPA) is a five-year agreement between the Minister for Health on behalf of the Commonwealth of Australia, the Pharmacy Guild of Australia (the Guild) and the Pharmaceutical Society of Australia (PSA) that governs, amongst other things, the remuneration arrangements for Approved Pharmacists for the supply of medicines listed on the Pharmaceutical Benefits Scheme.

  • The 6CPA includes three key funding elements: community pharmacy remuneration; ensuring that all Australians have timely access to the Pharmaceutical Benefits Scheme (PBS) medicines they require regardless of the cost of the medicine or where they live; and community pharmacy programs directed at improving consumer management of their medications and delivering primary healthcare services through community pharmacy.

  • Highly specialised drugs provided to JH&FMHN patients who are non-Australian residents, not covered by a Reciprocal Health Care Agreement are not entitled to a subsidy through the Pharmaceutical Benefits Scheme (PBS) under section 100 of the National Health ▇▇▇ ▇▇▇▇.

  • The Signatories recognise that community pharmacy is an integral part of the Australian health care system through its role in supporting the Pharmaceutical Benefits Scheme.

  • The Australian Government is seeking to continually improve transparency and accountability for the use of funds in relation to the Pharmaceutical Benefits Scheme, including through this Agreement.

  • The deidentified patient data collection and linkage activities for this Agreement will relate to patients with chronic and complex conditions, and will include provision of Admitted Patient Care National Minimum Data Set (NMDS), Medicare Benefits Schedule (MBS), Pharmaceutical Benefits Scheme (PBS), Emergency Department NMDS and National Death Index (NDI) data initially.